In both B16-F10 (Figure 1C) and CT26LacZ (Figure 1D) tumors, 49 and 42% CD4+ resident T cells expressed PD-1, respectively, which increased to 58% in both tumor types following treatment with NDV. This evidence concerns the gene PDCD1 and neoplasm.